Jolanta Węgłowska

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Mark Lebwohl, Bruce Strober, Alan Menter et al. · New England Journal of Medicine · 2015 · 806 citations · Full text

Medicine, Dermatology, Pharmacotherapy +10

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg et al. · JAMA Dermatology · 2023 · 143 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study

Kim Papp, H. Bachelez, Antonio Costanzo et al. · Journal of the American Academy of Dermatology · 2017 · 137 citations · Full text

Medicine, Clinical Sciences, Dermatology +13

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)

Mark Lebwohl, Andrew Blauvelt, C. Paul et al. · Journal of the American Academy of Dermatology · 2018 · 131 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea

Martin Schaller, Lajos Kemény, Blanka Havlíčková et al. · Journal of the American Academy of Dermatology · 2019 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13